is tirzepatide fda approved for obesity Lilly's Zepbound (aka tirzepatide) Lands Approval Weight Loss FDA grants fast track designation

Kidney Int (2014) 86(5):10578

Zepbound Zepbound (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved for weight management

Does Ozempic Cause Heart Problems

In this Analysis, we searched for relevant literature on the effects of GLP-1RAs across a range of illnesses, gathering and describing the available pre-clinical and mechanistic (278 studies) and clinical (96 studies) evidence for cognitive disorders, substance-use disorders, psychotic disorders, mood and anxiety disorders, eating disorders, and others

Telehealth platforms specializing in weight care can provide virtual consultations with licensed clinicians experienced in weight care, making it convenient to explore whether medications like Foundayo might be right for you